Engage Wealth Management Partners with Cure Leukaemia
Cure Leukaemia is delighted to announce a new corporate partnership with Engage Wealth Management supporting blood cancer patients across the UK.
The firm’s Founder and Managing Director, Oliver McDonald, was diagnosed with leukaemia at just four years old. Having overcome the disease as a child, Oliver has carried that experience with him throughout his life, driving a personal mission to ensure future generations have access to the ground-breaking treatments and clinical trials needed to defeat blood cancer.
To kick off the partnership, Oliver took on the London 2 Brighton Cycle Ride this September, coinciding with both Blood Cancer Awareness Month and Childhood Cancer Awareness Month.
Beyond the saddle, Engage Wealth Management is embedding its support directly into its core business model. The firm has pledged to donate a percentage of its ongoing business income directly to Cure Leukaemia, alongside actively leveraging its network to raise further vital funds and awareness.
Reflecting on the partnership and his personal connection to the cause, Oliver McDonald, Founder and Managing Director of Engage Wealth Management, said:
“Having been diagnosed with leukaemia when I was just four years old, this is a cause that is extremely close to my heart. I know firsthand the emotional and physical toll a diagnosis takes on patients and their families, as well as how critical medical research and advancements are in saving young lives.
“Setting up Engage Wealth Management was about building a business with purpose, and supporting Cure Leukaemia is a core part of that commitment. Riding London 2 Brighton during Blood Cancer Awareness Month is just the beginning. By donating a percentage of our business income, we want to ensure Cure Leukaemia can continue funding the research nurses and pioneer clinical trials that truly change and save lives every day.”
Welcoming the support, Bhupinder Dhillon, Business Development Manager at Cure Leukaemia, commented:
“We are absolutely thrilled to welcome Oliver and the team at Engage Wealth Management into the Cure Leukaemia family. Oliver’s personal journey makes this partnership incredibly poignant and inspires everything we do.
“Engage Wealth Management is a fantastic example of how a business can build meaningful charity support right into the fabric of its organisation. By combining direct income donations with awareness initiatives and high-impact challenge events like London 2 Brighton, their support will directly fund our clinical trial network, connecting blood cancer patients to life-saving treatments. We are immensely grateful for their commitment and wish Oliver the very best of luck on his ride this September!”
To learn how your business can partner with Cure Leukaemia and make a direct impact on the fight against blood cancer, please contact Bhupinder Dhillon at bhupinder@cureleukaemia.co.uk.